BEVILACQUA, GENEROSO
 Distribuzione geografica
Continente #
NA - Nord America 28.525
AS - Asia 10.380
EU - Europa 9.148
SA - Sud America 1.351
AF - Africa 319
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 49.744
Nazione #
US - Stati Uniti d'America 23.275
CA - Canada 5.153
SG - Singapore 3.199
CN - Cina 3.155
IT - Italia 2.160
PL - Polonia 1.683
HK - Hong Kong 1.564
SE - Svezia 1.293
BR - Brasile 1.150
BG - Bulgaria 787
DE - Germania 712
VN - Vietnam 702
TR - Turchia 541
UA - Ucraina 500
FI - Finlandia 420
GB - Regno Unito 419
KR - Corea 389
RU - Federazione Russa 343
FR - Francia 339
IN - India 191
CH - Svizzera 172
JP - Giappone 142
BD - Bangladesh 104
AT - Austria 95
CI - Costa d'Avorio 81
BE - Belgio 62
IQ - Iraq 59
AR - Argentina 57
ZA - Sudafrica 51
SA - Arabia Saudita 49
PK - Pakistan 47
NL - Olanda 46
SN - Senegal 45
MX - Messico 43
ID - Indonesia 39
VE - Venezuela 35
UZ - Uzbekistan 33
EC - Ecuador 31
CO - Colombia 26
MA - Marocco 26
KE - Kenya 22
BJ - Benin 20
JO - Giordania 20
ES - Italia 19
IE - Irlanda 17
TN - Tunisia 16
AE - Emirati Arabi Uniti 15
CZ - Repubblica Ceca 15
NG - Nigeria 15
UY - Uruguay 13
AU - Australia 12
EG - Egitto 12
PH - Filippine 12
KZ - Kazakistan 11
PY - Paraguay 11
BO - Bolivia 10
GR - Grecia 10
IL - Israele 10
MY - Malesia 10
OM - Oman 10
PE - Perù 10
AZ - Azerbaigian 9
NP - Nepal 9
PS - Palestinian Territory 9
LB - Libano 8
JM - Giamaica 7
LT - Lituania 7
RO - Romania 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
AL - Albania 6
BH - Bahrain 6
BY - Bielorussia 6
CL - Cile 6
DZ - Algeria 6
HU - Ungheria 6
KG - Kirghizistan 6
TH - Thailandia 6
BB - Barbados 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
PA - Panama 5
CG - Congo 4
ET - Etiopia 4
EU - Europa 4
IR - Iran 4
NI - Nicaragua 4
PR - Porto Rico 4
HN - Honduras 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
RS - Serbia 3
TZ - Tanzania 3
AO - Angola 2
BM - Bermuda 2
BZ - Belize 2
CR - Costa Rica 2
GY - Guiana 2
HR - Croazia 2
KH - Cambogia 2
Totale 49.699
Città #
Montreal 4.600
Woodbridge 2.877
Ashburn 2.246
Ann Arbor 2.135
Singapore 1.848
Fairfield 1.761
Houston 1.610
Hong Kong 1.546
Chandler 1.431
Dallas 1.097
San Jose 1.059
Santa Clara 854
Sofia 786
Seattle 760
Milan 721
Wilmington 663
Beijing 633
Jacksonville 629
Cambridge 627
Shanghai 568
Hefei 498
Ottawa 498
New York 490
Seoul 387
Izmir 343
Princeton 336
Boardman 332
Nanjing 306
Lawrence 302
Medford 285
Lauterbourg 258
Los Angeles 233
Des Moines 225
Serra 195
Bern 170
Dearborn 160
Florence 143
Istanbul 140
The Dalles 140
Tokyo 137
Columbus 130
Dong Ket 123
Hanoi 122
Buffalo 118
Council Bluffs 114
Ho Chi Minh City 112
Nanchang 112
Jüchen 101
Pisa 101
San Diego 90
São Paulo 87
Redondo Beach 86
Frankfurt am Main 85
Falls Church 84
Vienna 83
Abidjan 81
Helsinki 72
Kunming 66
Rome 65
Redwood City 62
Ogden 61
Boulder 60
Shenyang 55
Brussels 54
Washington 53
Munich 51
Changsha 46
Dakar 44
Rio de Janeiro 44
Hebei 41
London 41
Pune 41
Lancaster 40
Tianjin 40
Norwalk 36
Bremen 33
Düsseldorf 33
Orem 33
Chicago 32
Jiaxing 31
Tashkent 30
Auburn Hills 29
Orange 29
Alessandria 28
Dhaka 28
Guangzhou 28
Fuzhou 24
Jakarta 24
Belo Horizonte 23
Brasília 23
Chennai 22
Da Nang 22
Indiana 21
Grafing 20
Jeddah 20
Jinan 20
Johannesburg 20
Nuremberg 20
Amman 19
Cotonou 19
Totale 37.261
Nome #
CORRELATION OF GENE EXPRESSION PROFILES WITH CLINICAL RESPONSE TO GEMCITABINE IN PANCREATIC CANCER 3.301
CANCER RISK AMONG THE RELATIVES OF PROBANDS WITH PANCEATIC DUCTAL ADENOCARCINOMA 3.222
Unusual findings of viral production (MuMTV) in murine mammary tumors (BALB/cfC3H). 255
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 253
Endothelial progenitor cells recruitment correlate with coronary artery disease severity 245
Ultrastructural features of the intestinal absorption of mouse mammary tumor virus in newborn BALB/cfRIII mice. 238
Cytogenesis of murine mammary tumors in BALB/cfC3H and BALB/cfRIII strains. 237
Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: New emerging cancer players 232
Association between RAD 51 rs1801320 and susceptibility to glioblastoma 228
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 225
Choroid Plexus carcinoma: a new case associated with a novel TP53 germ line mutation 223
Histones of human lung carcinoma and human lung tissue. Analysis by two-dimensional electrophoresis. 217
A new immunization and treatment strategy for mouse mammary tumor virus (MMTV) associated cancers 216
Stromal tumours : which diagnostic approach? 215
Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. 215
Spontaneous dissecting aneurysm of the aorta in a dog. 213
VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma. 213
c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules. 212
Quantitative determination of mammary tumor virus in individual samples of mouse milk. 211
A new microwave scanning system for imaging superficial organs. 209
Circulating endothelial progenitor cells are actively involved in the reparative mechanisms of stable ischemic myocardium 207
Tumor cell heterogeneity and metastasis. 205
Creating a tumor-resistant microenvironment: cell-mediated delivery of TNFα completely prevents breast cancer tumor formation in vivo. 203
Stromal IGF-II messenger RNA in breast cancer: relationship with progesterone receptor expressed by malignant epithelial cells 202
Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironment. 199
Metastatic cervical carcinoma presenting as primary thyroid cancer. Case report. 197
Ganglioglioma of the spinal cord. A case with a long survival. 196
Effects of primary chemotherapy on biological parameters of locally advanced breast cancer. 196
p53 nuclear accumulation in adenomatous hyperplasia and stage I endometrioid carcinoma. 196
Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in italian BRCA 1/2 carriers 196
Sparc-like protein 1 is a new marker of human glioma progression 196
Accessibilome of human glioblastoma: collagen-VI-alpha-1 is a new target and a marker of poor outcome. 196
Multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis: description of a new family. 195
Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT). 194
Endothelial progenitor cell homing in human myocardium in patients with coronary artery disease 193
Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers 192
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program 192
Development of combined DNA-based piezoelectric biosensors for the simultaneous detection and genotyping of high risk Human Papilloma Virus strains 191
A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma 191
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling 190
Feline immunodeficiency virus vector as a tool for preventative strategies against human breast cancer 188
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine 188
Tumor targeting in vivo and metabolic fate of 5-(Iodine-125)-Iodo-2’- Deoxyuridine following intratumoral injection in patients with colorectal cancer. 187
Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus 187
Identification and characterization of differentially expressed genes in tumor metastasis: the nm23 gene. 185
Phase II study of high-dose epirubicin in untreated patients with small-cell lung cancer. 184
Variability of the expression of muscle mitochondrial damage in ocular mitochondrial myopathy. 184
Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma. 184
Tumor targeting potential and metabolism of 5-(125-I)-Iodo-2’-Deoxyuridine injected intratumorally in patients with breast cancer. 183
Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer. 183
Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. 182
Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. 181
A low NM23.H1 gene expression identifyjng high malignancy human melanomas. 181
Enriched SSCP: a highly sensitive method for the detection of unknown mutations. Application to the molecular diagnosis of lung cancer in sputum samples 179
RNA based analysis of BRCA and BRCA gene alterations 179
Cyclins of phases G1, S and G2/M are overexpressed in aneuploid mammary carcinomas 179
Insulin-like growth factor II (IGF-II) immunohistochemistry in breast cancer: relationship with the most important morphological and biochemical prognostic parameters 178
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 177
A renin-secreting tumor 177
Molecular portrait of a rare case of metastatic glioblastoma: somatic and germline mutations using whole-exome sequencing 176
A case of cavernous haemangioma of the spleen. 176
Aspetti istologici della erosione e della riapposizione ossea nel colesteatoma otomastoideo infiltrante del bambino 175
The Stem Cell Factor-c-kit System and Mast Cells in Human Pancreatic Cancer 175
Absence of somatic mutations in the coding region of the WAF1/CIP1 gene in human breast, lung and ovarian carcinomas. A polymorphism at codon 31 175
A molecular computational model improves the preoperative diagnosis of thyroid nodules. 175
Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers 175
Cellular Transfection Evidence in Pancreatic Tumor Primary Cell Cultures Through Electroporation of Green Fluorescent Protein (GFP) 174
Tumor targeting potential and metabolism of 5 Iodo-2'-deoxyuridine injected intratumorally in patients with gastrointestinal or breast cancer. 174
Papillary lesions of the breast: a molecular progression? 173
Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype 173
Neoangiogenesis as prognostic indicator of survival in lung cancer. 172
NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression. 171
Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications 171
Markers of cell proliferation, apoptosis, and angiogenesis in thyroid adenomas: a comparative immunohistochemical and genetic investigation of functioning and nonfunctioning nodules 171
The KIT Exon 11 Stop Codon Mutation in Gastrointestinal Stromal Tumors: What Is the Clinical Meaning? 171
PALB2: a novel inactivating mutation in a Italian breast cancer family 170
Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population. 170
Torquetenovirus Infection and Ciliary Dysmotility in Children With Recurrent Pneumonia 169
CIRCULATING PROGENITOR CELLS CORRELATE TO CORONARY ARTERY DISEASE SEVERITY AND TO POLYDISTRECTUAL ATHEROSCLEROSIS 169
Neoangiogenesis: A putative marker of malignancy in non-small-cell lung cancer (NSCLC) development 168
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 168
Clinico-pathological correlations in a case of primary angiosarcoma of the pericardium. 167
Homozygosis Mutation in K-ras Oncogene in Primary Cell Culture from Pancreatic Ductal Adenocarcinoma. Characteristic of the Tumor or Adaptation in Vitro? 167
Evaluation of FHIT gene alterations in ovarian cancer 167
Ocular myopathy without ophthalmoplegia can be a form of mitochondrial myopathy. 167
Presence of endothelin-1 in the normal and pathological human thyroid. 167
Congenital mitral regurgitation due to 'posterior reinsertion' of chordae tendineae. 166
Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma. 166
Bio-morphological events in the development of the human female mammary gland from fetal age to puberty 165
p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations 165
Bone marrow necrosis foreshadowing acute lymphoid leukemia. 165
mdm2 gene alterations and mdm2 protein expression in breast carcinomas 165
Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases 164
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients 164
Establishment and Characterization of 4 New Human Pancreatic Cancer Cell Lines: Evidences of Different Tumor Phenotypes 164
Evidence for a novel gene associated with low tumor metastatic potential. 163
Cell cycle regulators in lung cancer 163
CARDIAC TOXICITY AND ANTITUMOR-ACTIVITY OF 4'-DEOXY-4'-IODO-DOXORUBICINOL 163
Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma 162
Cutaneous metastasis of a radiation - associated thyroid medullary carcinoma 162
Totale 24.896
Categoria #
all - tutte 118.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.572


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021463 0 0 0 0 0 0 0 0 0 0 120 343
2021/20223.393 57 195 53 290 649 478 67 185 170 128 135 986
2022/20233.757 502 391 256 394 409 575 33 274 553 21 299 50
2023/20249.191 440 347 392 172 481 595 73 47 56 6.274 62 252
2024/20258.465 18 350 74 547 781 726 645 521 807 1.127 990 1.879
2025/20268.110 544 1.295 1.230 479 747 842 1.467 348 400 737 21 0
Totale 50.017